October 11, 2021 -- Artisan Bio plans to highlight its CRISPR-engineered cell therapy platform at the Cell & Gene Meeting on the Mesa in Carlsbad, CA.
The company's STAR platform consists of a family of endonuclease-based editing systems to produce cell therapy design candidates. Artisan Bio has validated the platform with T cells, induced pluripotent stem cells and cancer cells, as well as industrial cell lines like CHO and HEK293, it said.
Already have an account? Sign in Here
To access all ScienceBoard content create a free account now: